Clinical trial
Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial
NCT02601586 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- November 30, 2020
- Enrollment
- 67 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.